Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Neoplasms (Phase 1/Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Breast Neoplasms, Male (Phase 1/Phase 2)
Carcinoma, Adenoid Cystic (Phase 1/Phase 2)
Carcinoma, Basal Cell (Phase 1/Phase 2)
Carcinoma, Mucoepidermoid (Phase 1/Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Carcinoma, Squamous Cell (Phase 1/Phase 2)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 1/Phase 2)
Gliosarcoma (Phase 1/Phase 2)
Granuloma (Phase 1/Phase 2)
Hypopharyngeal Neoplasms (Phase 1/Phase 2)
Laryngeal Neoplasms (Phase 1/Phase 2)
Mouth Neoplasms (Phase 1/Phase 2)
Nasopharyngeal Carcinoma (Phase 1/Phase 2)
Nasopharyngeal Neoplasms (Phase 1/Phase 2)
Neoplasm Metastasis (Phase 1/Phase 2)
Neoplasms (Phase 1/Phase 2)
Neuroblastoma (Phase 1/Phase 2)
Oropharyngeal Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Papilloma, Inverted (Phase 1/Phase 2)
Salivary Gland Neoplasms (Phase 1/Phase 2)
Tongue Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue